Liverprime Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Per cap Silybin-phosphatidylcholine (1:2 ratio) 120 mg, dL-α-tocopheryl acetate (vit E) 12 mg, thiamine mononitrate (vit B₁) 1.1 mg, riboflavin (vit B₂) 1.1 mg, niacinamide 14 mg, pyridoxine HCl (vit B₆) 1.3 mg, cyanocobalamin (vit B₁₂) 2.4 mcg, Ca pantothenate 5.4 mcg, Zn sulfate 5 mg

Indications/Uses

Food supplement.

Click to view Liverprime detailed prescribing information

Dosage/Direction for Use

1 cap once daily to tid.

Click to view Liverprime detailed prescribing information

Overdosage

View Liverprime overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity.

Click to view Liverprime detailed prescribing information

Special Precautions

Pregnancy & lactation.

Click to view Liverprime detailed prescribing information

Adverse Reactions

Silybin: GI distress, itching & headache may occur rarely. Phosphatidylcholine: Nausea, diarrhea, excessive fullness & increased salivation have occasionally been reported.

Click to view Liverprime detailed prescribing information

Drug Interactions

Silybin: May increased the effects of drugs metabolized by CP450 system (eg, erythromycin, nifedipine, tamoxifen, warfarin, clopidogrel, fexofenadine). May reduce effect of metronidazole. May decrease insulin requirements of diabetic patients w/ alcoholic liver cirrhosis. Milk thistle: May reduce the effectiveness of OCs.

Click to view Liverprime detailed prescribing information

Storage

View Liverprime storage conditions for details to ensure optimal shelf-life.

Description

View Liverprime description for details of the chemical structure and excipients (inactive components).

Action

View Liverprime mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Supplements & Adjuvant Therapy

ATC Classification

A05BA - Liver therapy ; Used in liver therapy.

Regulatory Classification

Non-Rx

Presentation/Packing

Form

Liverprime cap

Packing/Price

30's

Liverprime

Manufacturer:

PT Darya-Varia

Distributor:

UNILAB, Inc

Marketer:

Westmont